Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $8.9 billion.

  • Sanofi's Cash & Current Investments rose 1210.44% to $8.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $8.9 billion, marking a year-over-year increase of 1210.44%. This contributed to the annual value of $8.7 billion for FY2025, which is 744.4% up from last year.
  • According to the latest figures from Q4 2025, Sanofi's Cash & Current Investments is $8.9 billion, which was up 1210.44% from $10.4 billion recorded in Q3 2025.
  • Sanofi's Cash & Current Investments' 5-year high stood at $16.8 billion during Q2 2021, with a 5-year trough of $6.9 billion in Q1 2023.
  • For the 5-year period, Sanofi's Cash & Current Investments averaged around $10.1 billion, with its median value being $9.4 billion (2023).
  • Per our database at Business Quant, Sanofi's Cash & Current Investments surged by 6138.58% in 2021 and then plummeted by 3833.53% in 2023.
  • Over the past 5 years, Sanofi's Cash & Current Investments (Quarter) stood at $11.6 billion in 2021, then grew by 12.36% to $13.0 billion in 2022, then fell by 27.88% to $9.4 billion in 2023, then decreased by 15.15% to $8.0 billion in 2024, then grew by 12.1% to $8.9 billion in 2025.
  • Its Cash & Current Investments stands at $8.9 billion for Q4 2025, versus $10.4 billion for Q3 2025 and $8.4 billion for Q2 2025.